| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |